« Back to Farmacia Journal 3/2017
THE IMPACT OF COMBINED ADMINISTRATION OF SEROTONIN-SPECIFIC REUPTAKE INHIBITORS WITH ATORVASTATIN ON THE LIVER AND KIDNEYS. IN VITRO AND IN VIVO STUDIES
MARIOLA HERBET, MAGDALENA IZDEBSKA, MONIKA GAWROŃSKA-GRZYWACZ*, IWONA PIĄTKOWSKA-CHMIEL, JAROSŁAW DUDKA
Department of Toxicology, Medical University of Lublin, 8B Jaczewski Street, Lublin 20-090, Poland